Trexquant Investment LP reduced its position in CME Group Inc. (NASDAQ:CME) by 84.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,300 shares of the financial services provider’s stock after selling 17,600 shares during the period. Trexquant Investment LP’s holdings in CME Group were worth $413,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Global X Management Co. LLC raised its position in CME Group by 7.2% in the second quarter. Global X Management Co. LLC now owns 7,067 shares of the financial services provider’s stock worth $885,000 after buying an additional 472 shares during the period. Pioneer Investment Management Inc. raised its position in CME Group by 1,359.5% in the second quarter. Pioneer Investment Management Inc. now owns 697,380 shares of the financial services provider’s stock worth $87,340,000 after buying an additional 649,599 shares during the period. Advisor Partners LLC raised its position in CME Group by 5.9% in the second quarter. Advisor Partners LLC now owns 6,155 shares of the financial services provider’s stock worth $771,000 after buying an additional 341 shares during the period. Davis R M Inc. raised its position in CME Group by 5.4% in the second quarter. Davis R M Inc. now owns 109,490 shares of the financial services provider’s stock worth $13,713,000 after buying an additional 5,655 shares during the period. Finally, Honeywell International Inc. acquired a new position in CME Group during the second quarter worth $13,776,000. 83.25% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) opened at 125.92 on Wednesday. The company has a 50 day moving average price of $123.49 and a 200-day moving average price of $121.06. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $127.96. The stock has a market capitalization of $42.80 billion, a P/E ratio of 25.70 and a beta of 0.73.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same period in the previous year, the firm posted $1.14 EPS. CME Group’s revenue was up 2.1% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 2.10%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.
COPYRIGHT VIOLATION NOTICE: “CME Group Inc. (CME) Stake Lowered by Trexquant Investment LP” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/08/16/cme-group-inc-cme-stake-lowered-by-trexquant-investment-lp.html.
A number of equities analysts have recently weighed in on the company. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Royal Bank Of Canada set a $135.00 price objective on CME Group and gave the stock a “buy” rating in a research note on Tuesday, August 1st. Jefferies Group LLC reaffirmed a “buy” rating and issued a $134.00 price objective (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $127.00 price objective on shares of CME Group in a research note on Friday, July 14th. Finally, Citigroup Inc. assumed coverage on CME Group in a research note on Wednesday, July 12th. They issued a “buy” rating and a $140.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $131.63.
In related news, Chairman Terrence A. Duffy sold 21,815 shares of CME Group stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total value of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at approximately $13,715,985.79. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 10,265 shares of CME Group stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total value of $1,209,730.25. Following the completion of the sale, the insider now owns 21,690 shares in the company, valued at $2,556,166.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 91,085 shares of company stock worth $11,242,896. 0.61% of the stock is currently owned by insiders.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.